Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Inhibition of His-tagged human recombinant BLK expressed in insect cells at 200 nM by Z'-lyte assay
Assay data:1 Tested
SummaryPubMed CitationRelated BioAssays by Target
Inhibition of BLK (unknown origin) by Z'LYTE assay
Assay data:2 Active, 2 Activity ≤ 1 µM, 2 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Inhibition of BLK (unknown origin) at 1 uM relative to control
Inhibition of BLK (unknown origin) assessed as ratio of Kinact/Ki
Assay data:3 Tested
Inhibition of BLK (unknown origin) incubated for 1 hr in presence of ATP by Z'LYTE assay
Assay data:1 Active, 1 Activity ≤ 1 nM, 1 Activity ≤ 1 µM, 1 Tested
Inhibition of BLK (unknown origin) at 500 nM relative to control
Inhibition of human BLK preincubated for 1 hrs followed by substrate addition and measured after 1 hrs in the presence of ATP at Km concentration by TR-FRET assay
Assay data:1 Active, 1 Activity ≤ 1 µM, 1 Tested
Binding affinity to BLK (unknown origin) assessed as strong interaction at 100 nM
Assay data:1 Active, 1 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by Target
Inhibition of human BLK at 1 uM by hotspot assay relative to control
Induction of BLK degradation in human K562 cells assessed as maximum degradation relative to control
Induction of BLK degradation in human K562 cells
HotSpot Assay from US Patent US11542261: "Substituted Imidazo[1,2-a]-pyridines as IRAK 1/4 and FLT3 inhibitors"
Assay data:30 Active, 6 Activity ≤ 1 nM, 30 Activity ≤ 1 µM, 30 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by DepositorRelated BioAssays by Target
Selectivity interaction (KinomeScan (DiscoverX, competition-binding assay)) EUB0000596aBDA BLK
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
Selectivity interaction (KinomeScan (DiscoverX)) EUB0000252b BLK
SummaryRelated BioAssays by Target
Selectivity interaction (Kinase panel (ProQinase, FlashPlate?-based radiometric assay, 10 M ATP)) EUB0000006b BLK
Selectivity interaction (Z?-LYTE assay) EUB0000638a BLK
Selectivity interaction (KinomeScan (DiscoverX)) EUB0000147b BLK
Selectivity interaction (Ambit kinome screening platform (Ambit phage-based competition binding assay)) EUB0000624a BLK
Affinity Biochemical interaction (33P-ATP and filter-binding assay (Reaction Biology)) EUB0000646a BLK
Affinity Phenotypic Cellular interaction (CellTiter-Glo Luminescent Cell Viability Assay (Promega; growth inhibitory activity in Rec-1 cells)) EUB0000646a BLK
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on